NCT06380491View on ClinicalTrials.gov

Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA)

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 22, 2023

Primary Completion Date

November 22, 2024

Study Completion Date

January 22, 2025

Conditions
Obstructive Sleep Apnea of Adult
Interventions
DRUG

Melatonin 3 MG Oral Tablet

Participants with OSA and nocturnal non-dipping Blood Pressure will be randomly assigned to a treatment with melatonin 3mg/d or to receive only the usual care.

Trial Locations (1)

Unknown

RECRUITING

National Institute of Medical Sciences and Nutrition Salvador Zubirán (INCMNSZ), Mexico City

All Listed Sponsors
collaborator

Universidad Nacional Autonoma de Mexico

OTHER

collaborator

Emory University

OTHER

lead

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

OTHER